SCHEMBL7500791

SCHEMBL7500791

CS(=O)(=O)c1ccc(-c2oc(Cc3ccccc3)nc2-c2ccccc2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 19/20 0.49
▸ PTGS1 P23219 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501268 0.92 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL7503061 0.91 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7510767 0.89 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7508181 0.89 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7506253 0.89 PTGS2 (0.43) PTGS2PTGS1
SCHEMBL7513276 0.89 CA1 (0.48) PTGS2PTGS1
SCHEMBL7503836 0.89 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL7506614 0.89 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL8552087 0.88 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7508189 0.88 RXRA (0.54) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 — — US disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback